Victoria, Australia

Shaun P Jackson

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Astrazeneca Ab, Kinacia Pty. Ltd.. Active years: 2005-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaun P Jackson. Retrieved from https://idiyas.com/inventor/shaun-p-jackson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

Average Co-Inventor Count = 7.3

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Melbourne, AU (2005 - 2009)
  • Victoria, AU (2009 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Shaun P Jackson

Introduction

Shaun P Jackson is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors for phosphoinositide 3-kinase β. With a total of five patents to his name, his work has implications for anti-thrombotic therapy.

Latest Patents

One of Shaun's latest patents focuses on the inhibition of phosphoinositide 3-kinase β. This invention relates to selective inhibitors of PI 3-kinase β, their use in anti-thrombotic therapy, and a method for screening compounds that exhibit selective inhibitory activity against this enzyme. The invention also introduces novel compounds that serve as inhibitors of PI 3-kinase.

Career Highlights

Throughout his career, Shaun has worked with prominent companies such as AstraZeneca and Kinacia Pty. Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.

Collaborations

Shaun has collaborated with notable professionals in his field, including Alan Duncan Robertson and Vijaya Kenche. These partnerships have further enhanced his research and development efforts.

Conclusion

Shaun P Jackson's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to the development of selective inhibitors for phosphoinositide 3-kinase β are paving the way for advancements in anti-thrombotic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…